A phase 1 study of 3 different schedules of the folic acid-tubulysin small-molecule drug conjugate EC1456 in pts with advanced solid tumors

Date 04 March 2015
Event 13th International Congress on Targeted Anticancer Therapies
Session Poster awarding ceremony
Topics Anti-Cancer Agents & Biologic Therapy
Drug Development
Presenter Binh Nguyen